Clinical Trials Directory

Trials / Completed

CompletedNCT02948660

A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness

EEG Dynamics Induced by Zolpidem Forecasts Consciousness Evolution in Prolonged Disorders of Consciousness and Quantification of EEG Reactivity Predicts Recovery of Consciousness

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The research contains two parts. Part 1: To explore whether EEG responses to zolpidem can assess consciousness circuit integrity and predict the evolution of consciousness in patients with prolonged disorders of consciousness; Part 2: To explore if quantitative EEG reactivity might predict the prognosis of disorders of consciousness.

Conditions

Interventions

TypeNameDescription
DRUGZolpidem Tartrate TabletsAll participants were administered 10 mg of zolpidem tartrate tablets either via a feeding tube (for patients with prolonged disorders of consciousness) or orally.

Timeline

Start date
2017-12-01
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2016-10-28
Last updated
2022-05-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02948660. Inclusion in this directory is not an endorsement.